Exercise Training in Women With Metastatic Breast Cancer
FITCAN
Randomized Controlled Trial of a Combined Exercise Training Program on Physical Function and Quality of Life in Women With Metastatic Breast Cancer
1 other identifier
interventional
78
1 country
1
Brief Summary
The primary objective of the study is to evaluate the effects of exercise on physical function, physical fitness, and body composition, with the main components including muscular strength, cardiorespiratory fitness, muscle mass, fat mass, and fat-free mass. The secondary objectives are to examine exercise adherence and the effects of exercise on health-related quality of life (HRQoL), cancer-related fatigue, and sleep quality. Additionally, the feasibility and safety of the exercise program will be assessed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable cancer
Started Apr 2026
Typical duration for not_applicable cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 17, 2026
CompletedStudy Start
First participant enrolled
April 1, 2026
CompletedFirst Posted
Study publicly available on registry
April 13, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
April 13, 2026
April 1, 2026
2 years
March 17, 2026
April 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Cardiorespiratory endurance and functional capacity
6MWT was performed as a parameter of cardiorespiratory endurance and functional capacity. Participants were instructed to walk back and forth along a flat, straight 25m corridor for six minutes, covering as much distance as possible at a self-selected pace. The total distance walked (in meters) was recorded as the primary outcome.
Baseline and week 24 (post exercise intervention)
Lower-limb muscle strength
Lower-limb muscle strength was assessed using the five-repetition sit-to-stand test (5xSTS), according to the European Working Group on Sarcopenia in Older People (EWGSOP2)¹. Participants were instructed to stand up and sit down five times as quickly as possible, with their arms crossed over the chest. The total time to complete the test was recorded in seconds (s) and used as an indicator of muscle strength. All assessments were performed by a trained evaluator
Baseline and week 24 (post exercise intervention)
Handgrip strength
Muscle strength was assessed using a handgrip dynamometer (SH5001, Saehan Grip, South Korea). Participants performed three maximal voluntary contractions with each hand in an alternating sequence, with a one-minute rest interval between trials. The highest value (kg) achieved was used for analysis. All measurements wer
Baseline and week 24 (post exercise intervention)
Secondary Outcomes (3)
Body composition
Baseline and week 24 (post exercise intervention)
Health-related quality of life
Baseline and week 24 (post exercise intervention)
Fatigue
Baseline and week 24 (post exercise intervention)
Study Arms (2)
Exercise group
EXPERIMENTALThe exercise group will be instructed to complete 48 supervised, multicomponent physical training sessions over a 24-week period, with a frequency of two sessions per week on non-consecutive days.
Control group
NO INTERVENTIONParticipants in the waitlist control group received standard medical care, without any exercise program or specific exercise recommendations. To maintain contact with the investigators and minimize study dropout, the waitlist control group received general health information through monthly online meetings.
Interventions
The multicomponent exercise intervention included a 10-minute warm-up consisting of balance, coordination, and stretching exercises. The main component was resistance training targeting the major muscle groups of the upper and lower body to improve strength and muscle mass. Six to eight exercises were performed using body weight, resistance bands, and dumbbells. Training progression was achieved by increasing load, repetitions, and/or sets, guided by the Borg 0-10 rating of perceived exertion scale, when health status allowed. The aerobic component consisted of walking, progressing to beginner-level running using short running intervals (50-100 m) interspersed with walking until longer continuous distances were achieved. Heart rate was monitored throughout the aerobic session.
Eligibility Criteria
You may qualify if:
- Women aged ≥ 18 years;
- Confirmed diagnosis of stage IV (metastatic) breast cancer;
- Currently undergoing medical treatment;
- Willingness and functional independence to participate in the exercise program;
- Medical clearance to engage in structured physical exercise.
You may not qualify if:
- Presence of unstable bone metastases.
- Untreated or symptomatic brain metastases;
- Evidence of severe cardiovascular disease identified by electrocardiogram (ECG);
- Severe active infection;
- Uncontrolled severe respiratory insufficiency or dependence on supplemental oxygen at rest or during exercise;
- Uncontrolled severe pain;
- Any other medical condition contraindicating participation in physical exercise;
- Conditions that impair adherence to study procedures or the ability to provide informed consent;
- Pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidade Estadual de Londrina, Londrina
Londrina, Paraná, 86047-597, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Participants and investigators were not blinded to group assignment, given the nature of the intervention.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 17, 2026
First Posted
April 13, 2026
Study Start
April 1, 2026
Primary Completion (Estimated)
April 1, 2028
Study Completion (Estimated)
December 1, 2028
Last Updated
April 13, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
On reasonable request